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Abstract Fluorescence and bioluminescence imaging
have different advantages and disadvantages depending
on the application. Bioluminescence imaging is now the
most sensitive optical technique for tracking cells, pro-
moter activity studies, or for longitudinal in vivo preclin-
ical studies. Far-red and near-infrared fluorescence imag-
ing have the advantage of being suitable for both ex vivo
and in vivo analysis and have translational potential,
thanks to the availability of very sensitive imaging in-
strumentation. Here, we report the development and val-
idation of a new luciferase fusion reporter generated by
the fusion of the firefly luciferase Luc2 to the far-red
fluorescent protein TurboFP635 by a 14-amino acid link-
er peptide. Expression of the fusion protein, named
TurboLuc, was analyzed in human embryonic kidney
cells, (HEK)-293 cells, via Western blot analysis, fluo-
rescence microscopy, and in vivo optical imaging. The
created fusion protein maintained the characteristics of
the original bioluminescent and fluorescent protein and
showed no toxicity when expressed in living cells. To
assess the sensitivity of the reporter for in vivo imaging,
transfected cells were subcutaneously injected in animals.
Detection limits of cells were 5×103 and 5×104 cells for
bioluminescent and fluorescent imaging, respectively. In
addition, hydrodynamics-based in vivo gene delivery
using a minicircle vector expressing TurboLuc allowed
for the analysis of luminescent signals over time in deep
tissue. Bioluminescence could be monitored for over
30 days in the liver of animals. In conclusion, TurboLuc
combines the advantages of both bioluminescence and
fluorescence and allows for highly sensitive optical im-
aging ranging from single-cell analysis to in vivo whole-
body bioluminescence imaging.
Keywords Fluorescence/luminescence . Cell systems/
single-cell analysis . Bioanalytical methods
Introduction
From its early development in the 1990s, in vivo optical
imaging (OI) demonstrated a growing interest by the
scientific community and a large number of applications
in many research areas from plant research to biochemi-
cal, biopharmaceutical, and biomedical sciences [1]. This
is due to the fact that OI techniques are easy to perform,
with low cost and high throughput. Optical imaging is
usually performed by the use of reporter genes, appropri-
ate substrates for luminescent reactions or luminescent
compounds (e.g., fluorescent probes) in order to under-
stand the dynamics of in vivo molecular events in cells or
in small animals [2]. In the last decades, optical reporter
genes for both fluorescence (FLI) or bioluminescence
imaging (BLI) have been extensively employed to image
molecular pathways at the transcriptional level or integrat-
ed into the genome for long-term expression and for the
development of transgenic animals [3–5]. In addition,
optical reporter genes have been modified to ameliorate
luminescent properties of the proteins like the photo- and
thermostability, maturation time, emission spectra, and
quantum yields. This resulted in improved in vivo sensi-
tivity and stability characteristics of optical reporters that
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enabled multiple readouts and (development of) high-
throughput assays. In research questions that warrant
monitoring molecular events from single cells to small
animals, strategies that combine the application of both
fluorescence and bioluminescence are preferable. At a
cellular level, fluorescent proteins provide a high spatial
and temporal resolution and good contrast for delineating
cell structures, making FLI explicitly suitable for (single)
cell imaging, while BLI allows for the noninvasive study
of ongoing biological processes in small laboratory ani-
mals. Reporter genes can be co-expressed in cells or
animal by two strategies: the first one is molecular clon-
ing of the reporter genes into bicistronic or tricistronic
constructs that allow the simultaneous transcription of
different genes while the second is development of fusion
proteins. The second strategy is preferable when there is a
need to co-localize the reporters in the cell during exper-
iments. Moreover, the chimerae may be more stable or
more soluble in the host cell than the native proteins
would be. Dual or triple fusion reporter proteins have
been developed to image cancer or stem cells and
employed Renilla luciferase or firefly luciferase (Photinus
pyralis) fused to green fluorescent proteins (GFPs) or red
fluorescent proteins (RFPs) [6–8]. In the last few years,
new far-red fluorescent proteins that are bright and suit-
able for cell and deep tissue imaging have been devel-
oped. Among these, TurboFP635 (scientific name
Katushka) shows emission maxima at 635 nm and is
seven- to tenfold brighter compared to the spectrally close
HcRed or mPlum fluorescent proteins. The protein is also
characterized by fast maturation as well as high pH sta-
bility and photostability [9]. The high photostability offers
advantages for stimulated emission depletion (STED) mi-
croscopy by which super-resolution is achieved in studies
to elucidate protein structure analysis at sub-organelle
level. These unique characteristics make TurboFP635 an
attractive component for biosensors in cells, for deep
tissue imaging, and long-term intravital imaging [10].
Also, for whole-body optical imaging in small laboratory
animals, TurboFP635 has shown to be superior to other
reported FPs [11].
Recently, our group and others confirmed the superior
bioluminescent imaging performance of the Luc2 reporter
gene for in vivo imaging using a single reporter as a result
of its high expression level in mammalian cells, stability,
spectrum of emission at 37 °C, and quantum yield of the
enzymatic reaction [12, 13]. Therefore, the combination of
TurboFP635 characteristics with the luciferase ones will offer
advantages in many bioanalytical applications like STED
microscopy, long-term fluorescence intravital imaging of sub-
cellular structures in live mice [14], intravital fiber-optic fluo-
rescence imaging [15], and whole-body optical imaging [11].
The resulted protein showed no altered biolumines-
cence of fluorescence properties compared to the individ-
ual counterparts, and it is expressed in mammalian cells
as a fused reporter. Expression of the TurboLuc fusion
protein was characterized by fluorescence microscopy and
in vivo optical imaging. Subsequently, the fusion reporter
gene was cloned into a minicircle vector and used for
hydrodynamic tail-vein injection in mice to analyze the
sustained expression of the fusion protein. Minicircles are
episomal DNA vectors that are produced as circular ex-
pression cassettes devoid of any bacterial plasmid DNA
backbone and have been shown to greatly increase the
efficiency of transgene expression in various in vitro and
in vivo studies [16, 17]. Their application is growing:
minicircles have recently been applied in human iPS cell
technology and are of great promise as a nonintegrating
method in stem cell engineering in a clinical setting [18,
19]. This novel luciferase fusion protein was revealed to
be a unique and useful tool for combined single-cell




The pGL3Luc2 vector was created by excision of luc2
gene with NcoI and XbaI from pGL4.10 and subcloned
into a pGL3-basic vector (Promega, Leiden, The Nether-
lands). The mammalian expression vector pTurboFP635-
N encoding far-red fluorescent protein TurboFP635
(Evrogen, Moscow, Russia) was used for the fusion of
Luc2 reporter gene at the N-terminal region of the
TurboFP635. Briefly, Luc2 gene was amplified from
pGL4.10 vector using the sense primer 5′-CCGCTAGC
AATGGAAGATGCCAAAAACAT-3′ with a NheI restric-
tion site and antisense primer 3′-CGTGACTGCTTGCC
GCCCTTCTTGGCCTT-5′ with a SalI restriction site.
Subsequently, the fragment was cloned in the multiple
cloning site of the pTurboFP635-N, allowing the genera-
tion of the fusion protein. The new vector was named
TurboLuc. Then, the fusion protein TurboLuc was ampli-
fied using the sense primer 5′CTCTAGAGCAATGGAA
GATGCCAAAAACAT-3′ with an XbaI restriction site
and antisense primer 3′-TGAATTCCATCAGCTGTGCC
CCAGTTTGCTA-5′ with an EcoRI site. The fragment
was subcloned into pMN502A-1, a parental minicircle
vector purchased from SBI (System Bioscience, Mountain
View, CA, USA), and the resulting vector was called
pMNTurboLuc. The minicircle vector, called MINI-
pMNTurboLuc, was then purified and isolated following
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the protocol of the MC-easy minicircle DNA production
kit (System Bioscience).
Cell culture and transfection
Human embryonic kidney cells (HEK-293) were cultured
in DMEM GlutaMAX (Invitrogen, Darmstadt, Germany)
supplemented with 10 % FCS (Sigma, St. Louis, USA),
1 % penicillin–streptomycin (Sigma), and 2 mM L-gluta-
mine (PAA). The cells were grown at 37 °C in a 5 %
CO2-humidified incubator. Cells (2×10
4/well) were seed-
ed in a 96-well plate and transfected with 0.1 μg of
pTurboLuc or pTurboFP635 for analysis of fluorescence
signals and immunofluorescence staining. For testing the
expression of TurboLuc in cells using a minicircle vector,
cells were seeded in a 24-well plate (5×104 cells/well)
and transfected with 1 μg of parental pMNTurboLuc or
MINI-pMNTurboLuc by using the reagents and following
the procedure described in the MC-easy minicircle DNA
production kit’s protocol.
Western blot analysis of luciferase protein
To confirm the presence of the fusion protein, we performed
Western blot analysis of cells transfected with pGL3Luc2,
pTurboLuc, and pTurboFP635-N. Two independent experi-
ments were carried out. Briefly, HEK-293 cells (5×105/well)
were seeded in six-well plates for 24 h, then transfected with
3.3 μg of plasmid DNA using FugeneHD transfection reagent
(Promega). After 24 h of treatment, cells were collected, and
the total amount of protein of each sample was determined by a
Pierce BCA protein assay kit (Thermo Scientific, Rockford,
USA). Fifteenmicrogram of whole cell extract was applied to a
10 % SDS-PAGE and transferred onto a nitrocellulose mem-
brane. After washing, the membrane was blocked in Tris–
phosphate-buffered saline (TPBS) 5 % bovine serum albumin
(BSA) and incubated with an anti-Luc rabbit polyclonal anti-
body (Luciferase antibody 20R-1419 from Fitzgerald Indus-
tries, Acton,MA, USA) diluted with 1:500 in TPBS, overnight
at room temperature. The blots were washed, exposed to HRP-
conjugated secondary antibodies for 1 h, and finally detected
using an enhanced chemiluminescence (ECL) reagent (Ther-
mo Scientific). Detection of ECL signals was performed with
ChemiDoc™MP System (Biorad, Hercules, CA, USA).
Immunofluorescence
Transfected HEK-293 cells were fixed in precooled 4 %
paraformaldehyde at room temperature for 10 min and
washed three times with PBS. The main procedures for
immunofluorescence staining were as follows: (1) incuba-
tion with 0.1 % Triton X-100 at room temperature for
30 min; (2) incubation with 5 % BSA at room temperature
for 30 min; (3) incubation with the primary antibody at
4 °C for 24 h (the primary antibody used was rabbit anti-
luciferase antibody (20R-1419) at a dilution of 1:500); (4)
the secondary antibody used was goat anti-rabbit IgG
fluorescein isothiocyanate (FITC), at 1:100, with incuba-
tion at room temperature in the dark for 2 h; (5) dilution
of DAPI at 1:1,000 in PBS at room temperature for 5 min;
and (6) mounting of slides with Fluoromount (Sigma;
F4680), analyzed with fluorescence microscopy.
Optical imaging
In vitro
Luciferase emission spectrum was determined as follows:
the medium in wells containing transfected cells was
replaced with phosphate-buffered saline, and D-luciferin
(Synchem, Germany) was added at a final concentration
of 0.5 mM. Luciferase activity was measured using an
IVIS Spectrum (Caliper, Alameda, CA, USA). The instru-
ment stage was kept at 37 °C, and the imaging setup was
field of view (FOV) C. Light output was measured using
an open filter and a series of band pass filter (20 nm)
ranging from 500 to 700 nm each for 5 s, 5 min after
substrate addition to live cells. For in vitro fluorescence
measurements, the instrument was set with an excitation
filter of 570 nm and an emission filter of 640 nm. All the
data are expressed in photon flux and analyzed with
Living Image Software 4.0 (Caliper, Alameda, CA,
USA). For the analysis of bioluminescence from cells
transfected with pMNTurboLuc or MINI-pMNTurboLuc,
cells were analyzed at different days after transfection
using One-Glo luciferase assay substrate (Promega) and
a plate luminometer (SpectraMax L luminometer, Molec-
ular Devices, Sunnyvale, CA, USA).
In vivo
All animal experiments were approved by the local committee
for animal health, ethics, and research of the Leiden Univer-
sity Medical Center. In the first set of experiments, different
amounts of transfected cells (5×102, 5×103, 5×104, 1×105,
2.5×105, and 5×105) were implanted subcutaneously in a
50-μl volume. BALB/c nu/nu mice (n=6) were used, and data
are presented as mean and standard deviation of luminescent
signals.
In the second set of experiments, a hydrodynamic injection
of 10 μg of MINI-pMNTurboLuc (dissolved in 2 ml of PBS
and injected in tail vein in 5–8 s) was performed inmice (n=3)
to evaluate the expression in deep organs such as the liver.
Light emission was collected using the IVIS Spectrum
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(Caliper, Alameda, CA, USA). For fluorescence measure-
ment, an excitation filter at 570 nm and an emission filter at
640 nm were used. D-Luciferin (150 mg/kg) was injected
intraperitoneally, and image acquisition started 10 min later
using a FOV C and a 30-s acquisition time.
Results and discussion
Construction of vectors and cell imaging
The choice of the amino acid linker is of great importance
in the construction of stable and bioactive fusion proteins.
In previous reports, generation of luciferase fusion pro-
teins has been performed by the addition of long linkers at
the C-terminal end of the luciferase gene [8]. In our
c o n s t r u c t , a l i n k e r o f 1 4 a m i n o a c i d s
(QSTVPRARDPPVAT) connecting the C-terminal region
of the Luc2 gene to the N-terminal region of the
TurboFP635 protein (Fig. 1a) appeared to be enough to
enable stability of the protein in vivo. Western blot anal-
ysis was carried out to confirm the correct expression of
the fusion protein by using an anti-luciferase antibody
(Fig. 1b). Whole protein extracts derived from cells
transfected with pTurboLuc revealed the presence of an
88-kDa protein band as a result of the fusion of Luc2
protein (62 kDa) and TurboFP635 (26 kDa). Immunoflu-
orescence staining on transfected cells using an anti-
luciferase antibody confirmed the correct expression of
the TurboLuc protein in cells (Fig. 1c) as the biolumines-
cent and fluorescent signals co-localize. Next, the fluores-
cence and bioluminescence emission characteristics of the
fusion protein were evaluated. HEK-293 cells were
Fig. 1 a Predicted protein configuration of TurboLuc based on the
sequence of amino acid residues [24]. b Western blot analysis of whole
extracts of cells transfected with pGL3Luc2, pTurboFP635, and
pTurboLuc using an anti-Luc antibody showing the presence of the fusion
protein of 88 kDa. Extracts from pGL3Luc2-transfected cells served as a
positive control showing the expression of the regular 62-kDa protein.
Extracts from pTurboFP635-expressing cells were used as a negative
control. c Immunofluorescence analysis of cells using an anti-luciferase
primary antibody and a FITC-labeled secondary antibody. Cells have
been imaged with a blue filter for DAPI (nuclei), a green filter for FITC
(Luc2), and a red filter for TurboFP635. Colocalization of red and green
signals demonstrates the expression of the fusion protein
Fig. 2 a Fluorescent signal output of cells expressing either TurboLuc or
TurboFP635 showed no significant differences. b Comparable normal-
ized bioluminescence emission spectra of HEK293 cells expressing either
TurboLuc or Luc2 at 37 °C
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transfected with an equal amount of pTurboLuc vector or
the parental pTurboFP635, and fluorescence emission was
analyzed 24 h later. As shown in Fig. 2a, both vectors
revealed a similar fluorescent signal output in transfected
live cells showing that the fusion of the reporter did not
affect fluorescent emission. Moreover, the measured lu-
ciferase spectra of pTurboLuc and Luc2 were similar in
cells at 37 °C (Fig. 2b). These data support the assump-
tion that the created TurboLuc fusion protein will most
probably retain the same efficiency as the native lucifer-
ase and fluorescent TurboFP635 counterparts when used
in (single) cell-based assays or in vivo imaging. This is of
particular importance since in some cases the fusion of a
fluorescent protein at the C-terminus of the firefly lucif-
erase has been shown to interfere with a correct fold and
function of the fusion protein when highly expressed in
certain cell types (e.g., neurons) or during aging and
disease [20–22].
Evaluation of in vivo fluorescence and bioluminescence
sensitivity imaging
To test the sensitivity of TurboLuc in vivo, pTurboLuc-
expressing HEK-293 cells were subcutaneously injected
in nude mice in an amount ranging from 5×102–5×105
(Fig. 3a). Bioluminescence signals were proportional to
the amount of injected cells (linear correlation coefficient
R2=0.98), and the detection limit was around 5×103 cells
(Fig. 3b). Fluorescence measurements also showed a lin-
ear correlation between signal emission and number of
injected cells (R2=0.86). However, the limit of detection
was 1 order of magnitude higher (5×104 cells). These
results imply that for superficial imaging of more than
5×104 cells, the fluorescence imaging can give an indica-
tion of the presence of the cells with no need to use a
luminescent substrate. However, most applications nowa-
days require the visualization of cells or molecular events
in deeper tissue.
Evaluation of efficiency of TurboLuc for deep tissue imaging
To evaluate TurboLuc imaging in deep tissue, the fusion
reporter gene was cloned into a parental minicircle vector
(MINI-pMNTurboLuc) to perform hydrodynamics-based
transfection of animals. Minicircle vectors allow for
sustained expression of a reporter as a result of the elim-
ination of the bacterial sequences from the parental plas-
mid that interfere with expression. Hydrodynamic injec-
tion of DNA allows for the expression of naked DNA
mostly in the liver, a deep tissue.
Fig. 3 a Representative bioluminescence and fluorescence images of a
mouse subcutaneously injected with 5×104, 1×105, 2.5×105, and 5×105
HEK-293 cells expressing TurboLuc (on the left) and 5×102, 5×103 cells
(on the right). Bioluminescence measurement allowed detecting 5×
103 cells while fluorescence imaging, 5×104 cells. b Graph showing
the linear correlation between luminescent signals and the number of
injected cells
Luciferase fusion protein for highly sensitive optical imaging 5731
First, pMNTurboLuc vector was compared with MINI-
pMNTurboLuc for bioluminescence imaging during
14 days in vitro. As shown in Fig. 4a, the comparison
between light outputs of the transfected cells showed the
retained expression after 7 and 14 days, while the signal
obtained with the pMNTurboLuc was lower at 7 days and
was not detectable after 14 days. In vivo bioluminescence
expression of the minicircle vector MINI-pMNTurboLuc
lasted for over 32 days in the liver as shown in Fig. 4b.
However, the fluorescent signals could not be detected.
TurboFP635 is one of the brightest red fluorescent
proteins [11]. The TurboLuc fusion protein can therefore
be considered as an optimized/superior reporter fusion
protein in terms of brightness and quantum yield and
stability with a large spectrum of applications in preclin-
ical research both in vitro and in vivo. Smart new lucif-
erase–fluorescent protein fusions can also be applied in
other imaging purposes. Recently, Saito K et al. devel-
oped a luciferase fusion reporter, which is a chimera of
enhanced Renilla luciferase and Venus [23]. Apart from
the main application of single-cell imaging, the authors
also showed some application for whole-body imaging.
Since Renilla luciferase requires coelenterazine as a sub-
strate, it will be possible to combine it with the developed
TurboLuc reporter enzyme that requires D-luciferin. This
will enable dual-color bioluminescence using the two
different substrates. Moreover, since Venus mostly emits
green light while Turbo635 has a far-red emission, dual-
color fluorescence can also be performed, enabling a
number of ex vivo applications (e.g., immunofluorescence
and microscopy on single cells). Recently, a fusion of
luciferase with a near-infrared protein combined near-
infrared imaging with optoacoustic imaging. This enabled
multimodality imaging and led to a better in vivo resolu-
tion [24, 25]. Moreover, TurboLuc can be subsequently
fused to a thymidine kinase (TK) reporter gene to allow
positron emission tomography (PET) imaging as an im-
proved version of the existing triple fusion reporter pub-
lished by Ray et al. [26] in 2007.
There are also opportunities to use this fusion reporter
gene for the generation of transgenic mice. Recently, Ray
and colleagues developed transgenic mice expressing a
triple fusion reporter in which Luc2 was fused to dTomato
and TK gene [27]. These mice ubiquitously expressed the
triple fusion reporter and could be used for multimodality
imaging purposes. A Cre-reporter transgenic animal ex-
pressing TurboFP635 has been reported, and transgenic
animals expressing the luciferase fused to GFP are also
Fig. 4 a Light emission from 2×104 lysed cells on different days after
transfection with pMNTurboLuc or the minicircle vector encoding
TurboLuc. Light emission of pMNTurboLuc is higher at day 7, while
expression of the minicircle vector encoding TurboLuc (MINI-
pMNTurboLuc) lasts for more than 14 days. b Representative images
of sustained Luc expression in the liver of an animal after hydrodynamic
injection of MINI-pMNTurboLuc
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available [28–30]. The expression of TurboFP635 or lu-
ciferase in these mice showed no toxicity and low immu-
nogenicity. This opens up the possibility to develop trans-
genic mice employing TurboLuc for highly sensitive im-
aging: these mice could be employed as a source of
luminescent cells (e.g., isolation of organs or mouse stem
cells) or as mouse strains for crossing with other mouse
models of disease. However, possible negative effects of
TurboLuc expression on embryo development, for the
generation of transgenics, are largely unknown and need
to be determined.
Conclusion
In this study, we report the generation and validation of a new
fusion protein that is a chimera between firefly luciferase
(Luc2) and TurboFP635 named TurboLuc. The expressed
fusion protein retained the good sensitivity of the Luc2 report-
er, and it showed no altered fluorescence emission. It can be
combined with other existing reporters for multicolor biolu-
minescence and fluorescence imaging. Therefore, the new
reporter protein shows great potential for imaging molecular
events from single cells to living intact animals.
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